DATA
VISIT DATA
Here are the gold-standard databases and data visualizations of R&D funding, approved products and candidates in the pipeline for neglected diseases, emerging infectious diseases and maternal health.
G-FINDER
G-FINDER
The annual tracker of R&D investment into new drugs, vaccines, diagnostics and vector control products for global health.
Infectious Disease R&D Tracker
Candidates in the pipeline and approved products for global health priorities across neglected diseases and emerging infectious diseases.
Maternal Health Pipeline
Database profiling medicines, diagnostics, and devices for seven significant pregnancy-related conditions.
Snakebite Envenoming Medicines Database
Database of all snakebite envenoming medicines with direct action on toxins.
Sexually Transmitted Infections Pipeline
Database of critical products for three STIs with an AMR risk.
Gynaecological Conditions Pipeline
Database of women's health products for three significant gynaecological conditions.
Innovation Spillover Tracker
A tracker of health innovations developed for LMICs that have translated into new applications and benefits in HICs.
INSIGHTS
VISIT INSIGHTS
Here you will find the analysis and insights to support decisions - whether you're funding research, setting policies, developing products or advocating for change.
Explore our hubs
The Investment Landscape Hub
A unique source of data and analysis tracking the funding of global health R&D and the pipeline of products in development. Powered by G-FINDER.
The Impact of Global Health R&D Hub
Global, UK and EU analyses of the health and economic impact of the last two decades of investment in global health R&D.
Women's Health Hub
This resource hub provides a suite of data, insights and tools to accelerate progress in women’s health R&D
Report Library
Our reports deliver critical insights using the evidence collected through G-FINDER and over two decades of independent analysis.
Health areas
This quick reference guide gives you a snapshot analysis of the R&D needs and the state of innovation to tackle each disease or condition we cover. It's a handy quick overview of what's needed to impact global health in these areas.
Hubs
Themed collections of all the data, analysis and tools you need to understand the landscape and make smart decisions on global health R&D.
Impact Global Health Dialogues
A series of dialogues with global health leaders to co-create an R&D investment roadmap that is fit for the future.
TOOLS
VISIT TOOLS
We've created some practical frameworks and tools you can use to assess and increase impact in global health.
Advocacy Kits
Join us in creating global health impact with our advocacy and press kits
Impact Framework
A global network of experts collaborated for two years to develop this comprehensive set of metrics that create an impact assessment framework for global health R&D.
100 Days Mission Scorecard
Is the world ready to deploy a new product to tackle an epidemic within 100 days of an outbreak?
ABOUT US
VISIT ABOUT US
Meet the team working to create a more equitable future through global health innovation and impact.
Our Team
Meet our diverse international team of experts, who collate and analyse data on global health funding and the innovation pipeline
Our Global Advisory Council
Bringing together some of the leading and most influential figures in global health, our Council challenges our thinking, expands our foresight and helps us with horizon scanning
Join Us
We build bridges, partnerships and consensus across the complex ecosystem of global health R&D players. Find out how to partner with us, commission our expertise, and how to join our team when we have vacancies.
Contact Us
Please get in touch with any questions or feedback. Between us, we cover most time zones so one of us will get back to you quickly.
Advocacy Kits
Join us in creating global health impact with our advocacy and press kits
NEWS

News & views

A collection of stories about our people, our research, and global health.

Browse all news

Photo of country flags for G-FINDER cover

10 min read

R&D funding for neglected diseases remained stable at $4.3bn in 2024

Dr Paul Barnsley summarises the 2024 funding landscape for neglected diseases

Dr Paul Barnsley

Dr Paul Barnsley5 Feb 2026

Ripple effect 2.0 image

5 min read

The Ripple Effect 2.0: video

Key messages from The Ripple Effect 2.0 which provides quantitative, country-specific proof points showing how innovations originally developed to address health needs in low- and middle-income countries (LMICs) are now improving health outcomes and delivering economic value across the United States, United Kingdom, Japan, and Europe.

Harriet Bell

Impact Global Health 20 Jan 2026

Ripple effect 2.0 image

10 min read

Why global health R&D is one of the smartest investments governments can make

Céline Aerts uncovers the wide range of spillover effects that global health R&D produces in high-income countries.

Céline Aerts

Dr Céline Aerts20 Jan 2026

PATH and IGH team at CPHIA 2025

10 min read

Africa at the crossroads: why African-led R&D is more important than ever

At CPHIA 2025, PATH and Impact Global Health convened a high-level discussion on why Africa must invest boldly and consistently in its own health R&D ecosystem to secure resilience, equity, and long-term sovereignty.

Harriet Bell

Impact Global Health 13 Jan 2026

WHS 1

5 min read

Rethinking global health R&D: a system under pressure, time for reform

Read the key insights from an Impact Global Health Dialogue held at the World Health Summit, Berlin October 2025

Harriet Bell

Impact Global Health 20 Oct 2025

Health Equity Podcast Cover Picture

30 min read

Maya Goldstein joins The Health Equity Podcast

Maya Goldstein, our Director of Strategy and External Affairs, joins Jayasree K. Iyer, CEO of the Access to Medicine Foundation, for this new episode of The Health Equity podcast on women's health R&D.

Harriet Bell

Impact Global Health 6 Oct 2025

Ripple effect

5 min read

The ripple effect: Video

Key messages from the September 2025 report on the ripple effect of high-income country investment in global health R&D

Harriet Bell

Impact Global Health 22 Sept 2025

endo video thumbnai

10 min read

Flying Blind shorts

Dr Cécile Ventola talks us through the key findings from the Flying Blind report.

Harriet Bell

Impact Global Health 10 Sept 2025

A mosquito on a leaf

10 min read

World Mosquito Day 2025

This year, we delve into our analysis of the 2025 Neglected Disease R&D Pipeline to understand where we stand in our fight against two vector-borne diseases, malaria and dengue, and what the next generation of innovations may bring.

Harriet Bell

Impact Global Health 20 Aug 2025

...